Goldman Sachs analyst Cindy Motz lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $42.00 (from $49.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE